PA
NVO

Profund Advisors’s Novo Nordisk NVO Stock Holding History

Profund Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$936K Sell
19,522
-562
-3% -$24.1K 0.03% 365
2026
Q1 		$738K Sell
20,084
-3,126
-13% -$148K 0.03% 432
2025
Q4 		$1.18M Buy
23,210
+14,367
+162% +$735K 0.04% 313
2025
Q3 		$491K Sell
8,843
-2,169
-20% -$127K 0.02% 516
2025
Q2 		$760K Buy
11,012
+380
+4% +$25.8K 0.03% 365
2025
Q1 		$738K Buy
10,632
+3,711
+54% +$306K 0.03% 368
2024
Q4 		$595K Buy
+6,921
New +$748K 0.02% 428
2023
Q4 		– Sell
-13,427
Closed -$1.22M – 1148
2023
Q3 		$1.22M Sell
13,427
-795
-6% -$70K 0.07% 238
2023
Q2 		$1.15M Sell
14,222
-2,722
-16% -$222K 0.06% 287
2023
Q1 		$1.35M Buy
16,944
+1,294
+8% +$91.8K 0.08% 213
2022
Q4 		$1.06M Buy
15,650
+2,618
+20% +$153K 0.07% 256
2022
Q3 		$649K Sell
13,032
-1,468
-10% -$78.6K 0.05% 321
2022
Q2 		$808K Sell
14,500
-1,346
-8% -$74.7K 0.05% 304
2022
Q1 		$880K Sell
15,846
-88
-0.6% -$4.52K 0.04% 354
2021
Q4 		$892K Sell
15,934
-11,654
-42% -$631K 0.03% 367
2021
Q3 		$1.32M Buy
27,588
+1,152
+4% +$55.7K 0.04% 283
2021
Q2 		$1.11M Buy
26,436
+710
+3% +$27.5K 0.04% 326
2021
Q1 		$867K Buy
25,726
+908
+4% +$32.3K 0.03% 354
2020
Q4 		$867K Buy
24,818
+710
+3% +$24.5K 0.04% 349
2020
Q3 		$837K Sell
24,108
-4,464
-16% -$149K 0.04% 317
2020
Q2 		$935K Buy
28,572
+5,184
+22% +$165K 0.05% 282
2020
Q1 		$704K Sell
23,388
-7,168
-23% -$213K 0.05% 288
2019
Q4 		$884K Sell
30,556
-3,458
-10% -$95.8K 0.04% 387
2019
Q3 		$879K Sell
34,014
-4,546
-12% -$115K 0.04% 363
2019
Q2 		$984K Buy
38,560
+544
+1% +$13.4K 0.05% 373
2019
Q1 		$994K Buy
38,016
+6,226
+20% +$153K 0.05% 339
2018
Q4 		$732K Buy
+31,790
New +$706K 0.05% 353

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Profund Advisors's NVO Position: Q2 2026 in Review

Profund Advisors reduced its Novo Nordisk (NVO) stake by 2.8% in Q2 2026, selling an estimated $24.1K and leaving 19,522 shares worth $936K. The position accounts for 0.03% of the portfolio, ranked #365.

Profund Advisors first reported a position in NVO in Q4 2018 and has held it in 27 quarters since. The position peaked at $1.35M in Q1 2023. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Profund Advisors held 19,522 shares of Novo Nordisk worth $936K as of Q2 2026.
  • Profund Advisors sold 562 Novo Nordisk shares in Q2 2026, an estimated $24.1K.
  • Novo Nordisk made up 0.03% of Profund Advisors's portfolio in Q2 2026, its #365 holding.
  • Profund Advisors first reported a position in Novo Nordisk in Q4 2018 and has held it in 27 quarters since.
  • Profund Advisors's Novo Nordisk position peaked at $1.35M in Q1 2023.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.